|
| |
| | | 66338 | | 27.09.2017 | | Amgen Switzerland AG | | | | | | | | | | | | | 07.05. | | | | 07.05. | | IPro |
| | Seq.-nr. | Préparation | Description | Forme galénique | Classe d'ATC | |
|---|
| 01 | Parsabiv 2.5 mg | Injektionslösung | Solution injectable (Etelcalcetidum 2.5 mg) | H05BX04 | | | 02 | Parsabiv 5.0 mg | Injektionslösung | Solution injectable (Etelcalcetidum 5 mg) | H05BX04 | | | 03 | Parsabiv 10.0 mg | Injektionslösung | Solution injectable (Etelcalcetidum 10 mg) | H05BX04 | |
|
|
|
